Legend Biotech Corp - SPONSORED ADS (LEGN)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q3 2024
91.2M
Holdings value Q3 2024
$4.45B
Value change Q3 2024
+$43.9M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
203
Number of buys Q3 2024
109
Number of sells Q3 2024
-81
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 91.2M $4.45B +$43.9M $48.73 204
2024 Q2 91.7M $4.06B +$156M $44.29 173
2024 Q1 86.6M $4.86B +$26.2M $56.09 190
2023 Q4 85.9M $5.17B -$78.5M $60.17 206
2023 Q3 86M $5.77B +$110M $67.17 200
2023 Q2 84.1M $5.8B +$1.14B $69.03 191
2023 Q1 68M $3.28B +$215M $48.22 160
2022 Q4 63.5M $3.17B -$29.2M $49.92 168
2022 Q3 63.8M $2.6B +$400M $40.80 157
2022 Q2 52.7M $2.9B +$118M $55.00 151
2022 Q1 51M $1.85B +$18.3M $36.34 136
2021 Q4 50.2M $2.34B +$500M $46.61 137
2021 Q3 39M $1.97B +$573M $50.56 89
2021 Q2 28.3M $1.16B +$122M $41.05 86
2021 Q1 26.4M $766M +$30.1M $29.02 70
2020 Q4 25.4M $717M +$16.9M $28.16 60
2020 Q3 24.5M $753M -$30M $30.87 50
2020 Q2 24.6M $1.04B +$1.04B $42.56 76